Profile | GDS5420 / 233625_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 481.97 | 67 |
GSM1296119 | B_lesional_pre-dose | 181.24 | 50 |
GSM1296076 | C_lesional_pre-dose | 204.04 | 54 |
GSM1296092 | D_lesional_pre-dose | 471.67 | 67 |
GSM1296103 | E_lesional_pre-dose | 339.24 | 61 |
GSM1296078 | F_lesional_pre-dose | 277.89 | 59 |
GSM1296107 | G_lesional_pre-dose | 207.76 | 52 |
GSM1296109 | H_lesional_pre-dose | 735.07 | 74 |
GSM1296080 | I_lesional_pre-dose | 829.64 | 76 |
GSM1296090 | J_lesional_pre-dose | 467.92 | 67 |
GSM1296074 | K_lesional_pre-dose | 198.46 | 55 |
GSM1296111 | L_lesional_pre-dose | 131.86 | 44 |
GSM1296099 | M_lesional_pre-dose | 317.66 | 59 |
GSM1296086 | O_lesional_pre-dose | 407.9 | 65 |
GSM1296117 | P_lesional_pre-dose | 330.68 | 60 |
GSM1296113 | Q_lesional_pre-dose | 115.25 | 40 |
GSM1296096 | R_lesional_pre-dose | 299.9 | 59 |
GSM1296105 | S_lesional_pre-dose | 359.87 | 62 |
GSM1296098 | T_lesional_pre-dose | 490.11 | 67 |
GSM1296101 | U_lesional_pre-dose | 404.17 | 64 |
GSM1296121 | V_lesional_pre-dose | 167.65 | 49 |
GSM1296088 | W_lesional_pre-dose | 557.05 | 69 |
GSM1296082 | X_lesional_pre-dose | 437.98 | 66 |
GSM1296115 | Y_lesional_pre-dose | 158.18 | 48 |
GSM1296084 | Z_lesional_pre-dose | 547.75 | 69 |
GSM1296072 | B_lesional_day8 | 266.17 | 56 |
GSM1296069 | L_lesional_day8 | 121.66 | 42 |
GSM1296071 | P_lesional_day8 | 240.16 | 53 |
GSM1296070 | Y_lesional_day8 | 159.22 | 46 |
GSM1296073 | V_lesional_day8 | 288.63 | 59 |
GSM1296034 | A_lesional_day15 | 949.28 | 78 |
GSM1296041 | G_lesional_day15 | 287.18 | 58 |
GSM1296035 | R_lesional_day15 | 443.02 | 65 |
GSM1296038 | U_lesional_day15 | 241.99 | 55 |
GSM1296047 | B_lesional_day15 | 221.41 | 53 |
GSM1296039 | E_lesional_day15 | 173.01 | 50 |
GSM1296042 | H_lesional_day15 | 185.58 | 50 |
GSM1296043 | L_lesional_day15 | 158.75 | 46 |
GSM1296037 | M_lesional_day15 | 520.68 | 68 |
GSM1296046 | P_lesional_day15 | 125.89 | 42 |
GSM1296044 | Q_lesional_day15 | 229.04 | 53 |
GSM1296045 | Y_lesional_day15 | 145.06 | 45 |
GSM1296025 | C_lesional_day15 | 577.36 | 70 |
GSM1296033 | D_lesional_day15 | 570.1 | 70 |
GSM1296027 | I_lesional_day15 | 938.74 | 78 |
GSM1296032 | J_lesional_day15 | 708.75 | 73 |
GSM1296024 | K_lesional_day15 | 497.95 | 68 |
GSM1296031 | W_lesional_day15 | 640.12 | 71 |
GSM1296028 | X_lesional_day15 | 740.8 | 74 |
GSM1296029 | Z_lesional_day15 | 664.78 | 72 |
GSM1296026 | F_lesional_day15 | 422.03 | 65 |
GSM1296030 | O_lesional_day15 | 765.45 | 74 |
GSM1296040 | S_lesional_day15 | 488.61 | 67 |
GSM1296036 | T_lesional_day15 | 435.18 | 65 |
GSM1296048 | V_lesional_day15 | 161.37 | 48 |
GSM1296059 | A_lesional_day43 | 518.51 | 68 |
GSM1296066 | G_lesional_day43 | 332.08 | 60 |
GSM1296060 | R_lesional_day43 | 316.28 | 60 |
GSM1296063 | U_lesional_day43 | 177.7 | 50 |
GSM1296064 | E_lesional_day43 | 164.35 | 50 |
GSM1296067 | H_lesional_day43 | 355.65 | 61 |
GSM1296062 | M_lesional_day43 | 600.53 | 70 |
GSM1296068 | Q_lesional_day43 | 191.08 | 49 |
GSM1296050 | C_lesional_day43 | 269.4 | 58 |
GSM1296057 | D_lesional_day43 | 503.03 | 67 |
GSM1296052 | I_lesional_day43 | 924.41 | 77 |
GSM1296054 | J_lesional_day43 | 844.99 | 76 |
GSM1296049 | K_lesional_day43 | 575.43 | 70 |
GSM1296055 | W_lesional_day43 | 370.37 | 62 |
GSM1296053 | X_lesional_day43 | 944.07 | 78 |
GSM1296058 | Z_lesional_day43 | 624.12 | 71 |
GSM1296051 | F_lesional_day43 | 268.22 | 58 |
GSM1296056 | O_lesional_day43 | 341.64 | 62 |
GSM1296065 | S_lesional_day43 | 289.01 | 58 |
GSM1296061 | T_lesional_day43 | 563.18 | 69 |
GSM1296095 | A_non-lesional_pre-dose | 301.43 | 59 |
GSM1296120 | B_non-lesional_pre-dose | 215.45 | 53 |
GSM1296077 | C_non-lesional_pre-dose | 484.71 | 67 |
GSM1296093 | D_non-lesional_pre-dose | 827.61 | 76 |
GSM1296104 | E_non-lesional_pre-dose | 250.48 | 56 |
GSM1296079 | F_non-lesional_pre-dose | 472.46 | 67 |
GSM1296108 | G_non-lesional_pre-dose | 234.35 | 54 |
GSM1296110 | H_non-lesional_pre-dose | 294.66 | 57 |
GSM1296081 | I_non-lesional_pre-dose | 1080.04 | 80 |
GSM1296091 | J_non-lesional_pre-dose | 585.66 | 70 |
GSM1296075 | K_non-lesional_pre-dose | 194.28 | 53 |
GSM1296112 | L_non-lesional_pre-dose | 226.84 | 52 |
GSM1296100 | M_non-lesional_pre-dose | 568.89 | 69 |
GSM1296087 | O_non-lesional_pre-dose | 764.39 | 75 |
GSM1296118 | P_non-lesional_pre-dose | 250.14 | 54 |
GSM1296114 | Q_non-lesional_pre-dose | 184.81 | 49 |
GSM1296097 | R_non-lesional_pre-dose | 291.9 | 58 |
GSM1296106 | S_non-lesional_pre-dose | 333.88 | 60 |
GSM1296102 | U_non-lesional_pre-dose | 490.77 | 67 |
GSM1296122 | V_non-lesional_pre-dose | 252.57 | 55 |
GSM1296089 | W_non-lesional_pre-dose | 535.82 | 68 |
GSM1296083 | X_non-lesional_pre-dose | 935.02 | 78 |
GSM1296116 | Y_non-lesional_pre-dose | 211 | 51 |
GSM1296085 | Z_non-lesional_pre-dose | 845.71 | 76 |